Opthea Limited - ADR

NASDAQ:OPT  
8.67
+0.03 (+0.35%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)359.78M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.13 Million
Adjusted EPS$0.21
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Opthea Limited - ADR Stock, NASDAQ:OPT

650 Chapel Street, Suite 0403, South Yarra, Victoria (VIC) 3141
Australia
Phone: +61.3.9826.0399
Number of Employees:

Description

Opthea Ltd. is a clinical stage biopharmaceutical company that engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It targets to treat neovascular age-related macular degeneration (wet AMD) and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984 and is headquartered in South Yarra, Australia.